William F. Borne

William F. Borne discloses dealings in Amedisys Inc to SEC (Form 4). Over a trading history stretching from 27 February 2006 to 1 April 2013, the count stands at 68 filings.

In open-market terms, that means 7 purchases worth €217k on one side and 19 sales worth €7.5M on the other. Netting one side against the other leaves €7.3M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 20 share grants and 15 option exercises.

A typical purchase (the median) is worth €8,934.

On 5 April 2013 came the latest disclosure, a share grant in Amedisys Inc. The last insider purchase was made public on 24 May 2012, 5,281 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.